(firstQuint)Flibanserin (Addyi) vs.

 Flibanserin and Sex Therapy.

 This is an unblinded study to be conducted at a single research center, San Diego Sexual Medicine.

 Subjects meeting inclusion and exclusion criteria will receive flibanserin for an 8-week run-in period to differentiate between responders and non-responders.

 Responders will be determined by a score of 1-3 on the Patient Global Impression of Improvement (PGI-I) at 8 weeks from baseline, and will be randomized 1:1 to receive study medication alone vs.

 study medication and sex therapy for an additional 12 weeks.

.

 Flibanserin (Addyi) vs.

 Flibanserin and Sex Therapy@highlight

Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 to receive study medication alone vs.

 study medication and sex therapy for 12 additional weeks.

